Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ocugen, Inc. - Common Stock (NQ: OCGN )

0.8050 -0.0036 (-0.45%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ocugen, Inc. - Common Stock

< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
Benzinga's Top Ratings Upgrades, Downgrades For June 11, 2021
Upgrades Barclays upgraded the previous rating for Ventas Inc (NYSE:VTR) from Equal-Weight to Overweight. In the first quarter, Ventas showed an EPS of $0.72, compared to... 
Via Benzinga
10 Biggest Price Target Changes For Friday
Barclays lowered Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) price target from $302 to $285. Vertex Pharmaceuticals shares fell 13.3% to $187.88 in pre-market trading.... 
Via Benzinga
Why Ocugen Plummeted by Nearly 30% Today
The company won't be getting emergency use authorization for Covaxin after all. 
Via The Motley Fool
Exposures COVID-19 Product Safety
66 Biggest Movers From Yesterday
Gainers Orphazyme A/S (NASDAQ: ORPH) shares jumped 302.3% to close at $21.00 on Thursday. Shares of the biopharmaceutical firm touched an intraday high of $77.77, running up 1,... 
Via Benzinga
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ocugen, Inc. and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
Mid-Afternoon Market Update: Nasdaq Rises 100 Points; Materialise Shares Slide
Toward the end of trading Thursday, the Dow traded up 0.25% to 34,531.98 while the NASDAQ rose 0.72% to 14,011.75. The S&P also rose, gaining 0.51% to 4,241.13. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
EQUITY ALERT: Rosen Law Firm Encourages Ocugen, Inc. Investors with Losses to Inquire About Class Action Investigation – OCGN
From Rosen Law Firm
Via Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers NuCana (NASDAQ:NCNA) shares moved upwards by 16.17% to $3.16 during Thursday's regular session. NuCana's stock is trading at a volume of 4.7 million shares... 
Via Benzinga
Mid-Day Market Update: Yiren Digital Rises Following Q1 Results; Ocugen Shares Slide
Midway through trading Thursday, the Dow traded up 0.35% to 34,568.37 while the NASDAQ rose 0.5% to 13,981.31. The S&P also rose, gaining 0.46% to 4,238.79. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
42 Stocks Moving In Thursday's Mid-Day Session
Gainers Orphazyme A/S (NASDAQ: ORPH) surged 105% to $10.71. Medley Management Inc. (NASDAQ: MDLY) shares jumped 78% to $10.39 after gaining 9% on Wednesday. Medley LLC recently... 
Via Benzinga
Making Money in the Stock Market Is Easy -- If You Avoid This 1 Thing
Get-rich-quick strategies rarely work. 
Via The Motley Fool
Mid-Morning Market Update: Markets Open Higher; US Inflation Rate Increases to 5%
Following the market opening Thursday, the Dow traded up 0.54% to 34,632.83 while the NASDAQ rose 0.72% to 14,011.98. The S&P also rose, gaining 0.58% to 4,243.96. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
OCGN Stock: The COVAXIN News That Has Ocugen Plunging Today
Retail investors refuse to let OCGN stock die, even as the company makes it known that it wouldn't be applying for a crucial authorization. 
Via InvestorPlace
Exposures COVID-19
Why Ocugen Shares Are Getting Hammered Today
Ocugen Inc (NASDAQ: OCGN) shares were trading 22.18% lower off the open Thursday at $7.24 after the company announced it will pursue a biologics license application path for... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Verona Pharma (NASDAQ:VRNA) stock moved upwards by 15.2% to $7.5 during Thursday's pre-market session. The market value of their outstanding shares is at $434.... 
Via Benzinga
Could Ocugen Be a Millionaire-Maker Stock?
The ability of this biotech to sell its coronavirus vaccine in a timely manner has caused a lot of headaches for investors. 
Via The Motley Fool
Exposures COVID-19
3 Tips for COVID Vaccine Stock Investing Right Now
Coronavirus vaccine investing is far from over. 
Via The Motley Fool
Topics Cannabis
Exposures COVID-19 Cannabis
60 Biggest Movers From Yesterday
Gainers Ra Medical Systems, Inc. (NYSE: RMED) shares surged 87.3% to close at $9.14 on Monday on abnormally-high session volume. EXFO Inc. (NASDAQ: EXFO) gained 60.3% to settle... 
Via Benzinga
Why Ocugen Stock Fell 31.1% in May
The biopharmaceutical company, known for its portfolio of eye therapy drugs, has a COVID-19 vaccine in the works. 
Via The Motley Fool
Exposures COVID-19
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Nymox Pharmaceutical (NASDAQ:NYMX... 
Via Benzinga
OCGN stock: The Big COVAXIN News Boosting Ocugen Today
Today, OCGN stock is on the move as the company announced its intention to expand its commercialization rights to include Canada. 
Via InvestorPlace
When It Comes to Ocugen Stock I’m Damned If I Do or Don’t
After sprinting to $16.20 in early May, Ocugen’s fallen back to earth. What does it have to do to get OCGN stock back into double digits? 
Via InvestorPlace
This New Vaccine Market Could Be Bigger for Ocugen Than the U.S.
Ocugen is casting a wider net. 
Via The Motley Fool
Exposures COVID-19
I Would Hope Inovio Isn’t Attracting ANY Serious Money
It seems as though INO stock will have a tough time getting and staying in double digits 
Via InvestorPlace
The Same Problems Persist for Ocugen in Marketing Covaxin
OCGN stock is attempting an upward move on unrealistic expectations. There is no reason to believe it can move upward in the long term. 
Via InvestorPlace
Exposures COVID-19
28 Stocks Moving in Thursday's Pre-Market Session
Gainers GTT Communications, Inc. (NYSE: GTT) rose 41.6% to $3.54 in pre-market trading after jumping over 57% on Wednesday. Workhorse Group Inc. (NASDAQ: WKHS) rose 29.2% to $14... 
Via Benzinga
Did the FDA Slam the Door on Ocugen's Chances of Winning Authorization for Covaxin?
The agency's revised emergency-authorization guidance for COVID-19 vaccines appears to present a significant hurdle for Ocugen. 
Via The Motley Fool
Exposures COVID-19 Product Safety
FDA’s Vaccine Attitude, New Data Don’t Bode Well for Ocugen Stock
The FDA's recent warning that it could reject some applications for EUAs from vaccine makers does not portend well for Ocugen's aspirations. OCGN stock remains an excellent name to sell short. 
Via InvestorPlace
Exposures COVID-19 Product Safety
10 Current And Former Penny Stocks With High Short Interest As BB & GME Stock Attract More Reddit Interest
Reddit stocks have surged thanks to big moves in BB and GME. With short interest as the focus, here are a few penny stocks to watch right now. 
Via Talk Markets
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Tilray (NASDAQ:TLRY) shares incre... 
Via Benzinga
< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.